From the TCGA data, the two most predominant gene alterations and mutations reported were TP53 and CDKN2A, which were largely absent in HPV+ tumors, however, both HPV+ and HPV− HNSCC tumors shared similar amplifications in PIK3CA and SOX2 genes.8 The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.